Earnings highlights
Reported record managed revenue of $105.0 million, which grew
29% sequentially
-- Reported record total revenue of $96.5 million, which grew 28%
sequentially
-- Record Adjusted EBITDA of $20.0 million, which grew 45%
sequentially
-- Closed $300 million senior secured term loan facility
-- Opened Company's second adult-use dispensary and the first
adult-use dispensary on Cape Cod in Provincetown, MA and the
Company's third adult-use dispensary in Ware, MA
-- Completed acquisition of Select and enhanced management team
with key leadership appointments
-- Won retail and processing licenses in Utah and received
Clinical Registrant Designation by the Pennsylvania Department
of Heath permitting Curaleaf to open a cultivation and
processing facility and up to six dispensaries under the
Commonwealth's medical marijuana research program
source marketwatch
Reported record managed revenue of $105.0 million, which grew
29% sequentially
-- Reported record total revenue of $96.5 million, which grew 28%
sequentially
-- Record Adjusted EBITDA of $20.0 million, which grew 45%
sequentially
-- Closed $300 million senior secured term loan facility
-- Opened Company's second adult-use dispensary and the first
adult-use dispensary on Cape Cod in Provincetown, MA and the
Company's third adult-use dispensary in Ware, MA
-- Completed acquisition of Select and enhanced management team
with key leadership appointments
-- Won retail and processing licenses in Utah and received
Clinical Registrant Designation by the Pennsylvania Department
of Heath permitting Curaleaf to open a cultivation and
processing facility and up to six dispensaries under the
Commonwealth's medical marijuana research program
source marketwatch